Biocomposites announces new territories approved to promote STIMULAN® as an antibiotic carrier in bone and soft tissue
STIMULAN gives surgeons the freedom to choose the antibiotics that support their infection treatment strategy
Keele, UK, 11 October 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that Argentina and Taiwan are the latest territories to approve STIMULAN® as an antibiotic carrier that can be used in bone and soft tissue. They join a rapidly expanding list of territories which already includes UK, EU, Canada, Saudi Arabia, Mexico and South Africa. In Canada and South Africa, STIMULAN is also approved to assist in wound healing and to treat bacterial infection in soft tissue surrounding bone.
